Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

ATP helps prevent skin damage from vandetanib by reducing stress.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Upadacitinib improved multiple immune-related conditions in one patient.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Baricitinib is effective and safe for treating severe alopecia areata.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Targeting the RAAS with small molecules can improve cardiovascular disease treatments.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The drug showed promise in treating renal cell carcinoma with manageable side effects.